Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients - PACE-CME

Reduction in bleeding with genotypeguided strategy for choice of PYi in STEMI patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

What are the most important changes in the 2019 ESC/EAS Dyslipidemia Guidelines?
What are the most important changes in the 2019 ESC/EAS Dyslipidemia Guidelines?
ESC 2019
What are the most important changes in the 2019 ESC/EAS Dyslipidemia Guidelines?
- Prof. François Mach, MD
Lessons from ISAR-REACT 5 about which antiplatelet agent to choose in ACS patients
Lessons from ISAR-REACT 5 about which antiplatelet agent to choose in ACS patients
ESC 2019
Lessons from ISAR-REACT 5 about which antiplatelet agent to choose in ACS patients
- Prof. Freek Verheugt
Heterogeneity of treatment effects from intensive lifestyle intervention on CV events in T2DM
Heterogeneity of treatment effects from intensive lifestyle intervention on CV events in T2DM
ESC 2019
Heterogeneity of treatment effects from intensive lifestyle intervention on CV events in T2DM
- Jan Westerink, MD, PhD
NP metabolism associated with clinical outcomes in HF
NP metabolism associated with clinical outcomes in HF
ESC 2019
NP metabolism associated with clinical outcomes in HF
- Frank Gommans, MD, PhD